{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T08:05:10Z","timestamp":1792310710442,"version":"4.4.0"},"reference-count":60,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2021,1,2]]},"DOI":"10.1080\/21645515.2020.1765619","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T12:43:18Z","timestamp":1591965798000},"page":"205-210","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":22,"title":["Close the gap for routine mumps vaccination in Japan"],"prefix":"10.1080","volume":"17","author":[{"given":"Taito","family":"Kitano","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, The Hospital for Sick Children, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"e_1_3_3_2_1","first-page":"3","article-title":"Mumps and mumps vaccine: a global review","volume":"77","author":"Galazka AM","year":"1999","unstructured":"Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ. 1999;77:3\u201314.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_3_1","unstructured":"Japan Pediatric Society. Vaccination Schedule: vaccination Schedule Recommended by the Japan Pediatrics Society [Internet]. Tokyo: Japan Pediatric Society; 2018 [cited 2019 Nov 27]. Available from: https:\/\/www.jpeds.or.jp\/uploads\/files\/20180801_JPS%20Schedule%20English.pdf"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199103000-00007"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199103000-00008"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92311-X"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31818a8cc6"},{"key":"e_1_3_3_8_1","first-page":"326","article-title":"Present status of hearing loss due to mumps virus infection in Japan","volume":"45","author":"Morimoto N","year":"2017","unstructured":"Morimoto N. Present status of hearing loss due to mumps virus infection in Japan. Clin Virol. 2017;45:326\u201330. Japanese.","journal-title":"Clin Virol"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036121"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90420-A"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-9427"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5876(98)00010-X"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1970.02100070078008"},{"key":"e_1_3_3_14_1","unstructured":"World Health Organization. Media Center: immunization coverage [Internet]. Geneva: World Health Organization; 2019 [cited 2019 Nov 27]. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/immunization-coverage"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70282-2"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00038-016-0842-8"},{"issue":"24","key":"e_1_3_3_17_1","first-page":"2403","article-title":"Third Dose of MMR Vaccine for Mumps Control","volume":"377","author":"Plotkin SA","year":"2017","unstructured":"Plotkin SA. Third Dose of MMR Vaccine for Mumps Control. N Engl J Med. 2017 Dec 14;377(24):2403.","journal-title":"N Engl J Med"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703309"},{"key":"e_1_3_3_19_1","first-page":"3","article-title":"Should Mumps Be Higher Up on the Public Health Agenda in India? A Concern for Global Health Security","volume":"6","author":"Kadri SM","year":"2018","unstructured":"Kadri SM, Rehman SU, Rehana K, Brady AH, Chattu VK. Should Mumps Be Higher Up on the Public Health Agenda in India? A Concern for Global Health Security. Med Sci (Basel). 2018 Aug 7;6:3.","journal-title":"Med Sci (Basel)"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-016-0874-4"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4194-3"},{"key":"e_1_3_3_22_1","unstructured":"National Institute of Infectious Diseases. Infectious disease surveillance annual report [Internet]. Tokyo: National Institute of Infectious Disease Japan; 2019 [cited 2019 Dec 2]. Available from: https:\/\/www.niid.go.jp\/niid\/ja\/ydata\/8110-report-jb2017.html"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0385-8146(86)80001-3"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.09.022"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/ped.13916"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/ped.13502"},{"key":"e_1_3_3_27_1","first-page":"794","article-title":"Incidence of infectious diseases estimated by the surveillance data in 2002-2004 in Japan","volume":"53","author":"Hashimoto S","year":"2006","unstructured":"Hashimoto S, Kawado M, Murakami Y, et al. Incidence of infectious diseases estimated by the surveillance data in 2002-2004 in Japan. Nihon Koshu Eisei Zasshi. 2006;53:794\u201399.","journal-title":"Nihon Koshu Eisei Zasshi"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/00016489.2017.1300321"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/00016489.2017.1290826"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4557-0090-5.00007-0"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2004.10.001"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010239"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90684-9"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199705000-00009"},{"key":"e_1_3_3_35_1","first-page":"55","article-title":"Mumps vaccine effectiveness and adverse events: the need for 2-dose vaccination","volume":"49","author":"Ihara T","year":"2015","unstructured":"Ihara T. Mumps vaccine effectiveness and adverse events: the need for 2-dose vaccination. Nihon Syounikai Kaihou. 2015;49:55\u201360. Japanese.","journal-title":"Nihon Syounikai Kaihou"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.09.068"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.11.068"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.JJID.2018.276"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01324283"},{"key":"e_1_3_3_40_1","first-page":"100","article-title":"Estimation of the ef\ufb01cacy of three strains of mumps vaccines during an epidemic mumps in the Geneva canton (Switzerland)","volume":"46","author":"Chamot E","year":"1998","unstructured":"Chamot E, Toscani L, Egger P, Germann D, Bourquin C. Estimation of the ef\ufb01cacy of three strains of mumps vaccines during an epidemic mumps in the Geneva canton (Switzerland). Rev Epidemiol Sante Publique. 1998;46:100\u201307.","journal-title":"Rev Epidemiol Sante Publique"},{"key":"e_1_3_3_41_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.319.7206.352","article-title":"Comparative ef\ufb01cacy of three mumps vaccine during disease outbreak in eastern Switzerland: cohort study","volume":"319","author":"Schlegel M","year":"1999","unstructured":"Schlegel M, Osterwalder JJ, Galeazzi RL, Vernazza PL. Comparative ef\ufb01cacy of three mumps vaccine during disease outbreak in eastern Switzerland: cohort study. BMJ. 1999;319(7206):352.","journal-title":"BMJ"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.10.020"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.02.001"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60419-5"},{"key":"e_1_3_3_45_1","first-page":"302","article-title":"Aseptic meningitis after vaccination against measles and mumps","volume":"8","author":"Cizman M","year":"1989","unstructured":"Cizman M, Mozetic M, Radescek-Rakar R, Pleterski-Rigler D, Susec-Michieli M. Aseptic meningitis after vaccination against measles and mumps. Pediatr Infect Dis J. 1989;8:302\u201308.","journal-title":"Pediatr Infect Dis J"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-123-31599"},{"key":"e_1_3_3_47_1","article-title":"Cost and benefit of measles and mumps immunization in Austria","volume":"57","author":"Wiedermann G","year":"1979","unstructured":"Wiedermann G, Ambrosch F. Cost and benefit of measles and mumps immunization in Austria. Bull World Health Organ. 1979;57:625\u20159.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1155\/1997\/215175"},{"key":"e_1_3_3_49_1","article-title":"A benefit-cost analysis of mumps vaccine","volume":"136","author":"Kaplan JP","year":"1982","unstructured":"Kaplan JP, Preblud SR. A benefit-cost analysis of mumps vaccine. Am J Dis Child. 1982;136:362\u20154.","journal-title":"Am J Dis Child"},{"issue":"1","key":"e_1_3_3_50_1","first-page":"S131","article-title":"An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States","volume":"189","author":"Zhou F","year":"2004","unstructured":"Zhou F, Reef S, Massoudi M, et al. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. J Infect Dis. 2004;189(suppl 1):S131\u201345.","journal-title":"J Infect Dis"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.11150\/kansenshogakuzasshi1970.81.555"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.05.020"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.7774\/cevr.2017.6.2.120"},{"key":"e_1_3_3_54_1","first-page":"1","article-title":"Dynamic transmission model of routine mumps vaccination in Japan","volume":"3","author":"Kitano T","year":"2018","unstructured":"Kitano T. Dynamic transmission model of routine mumps vaccination in Japan. Epidemiol Infect. 2018 Dec;3:1\u20138.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"e_1_3_3_55_1","first-page":"46","article-title":"Parents\u2019 intention to take their children to mumps vaccination: influence of information provision and fee","volume":"62","author":"Sano T","year":"2012","unstructured":"Sano T, Sasaki T, Furukawa S, et al. Parents\u2019 intention to take their children to mumps vaccination: influence of information provision and fee. Fukushima Igaku Zasshi. 2012;62(2):46\u201351. Japanese.","journal-title":"Fukushima Igaku Zasshi"},{"key":"e_1_3_3_56_1","unstructured":"Ministry of Health Labour and Welfare of Japan. The 32nd Subcommittee Meeting on Adverse Reactions of the Committee on Immunization and Vaccines of the Health Sciences Council. Material 2: about the current status of immunization policy [Internet]. Tokyo: Ministry of Health Labour and Welfare of Japan; 2019. [cited 2019 Dec 2]. Available from: https:\/\/www.mhlw.go.jp\/content\/10906000\/000535717.pdf. Japanese."},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy469"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1302629"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.026"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.01.092"},{"key":"e_1_3_3_61_1","article-title":"Stopping the HPV vaccine crisis in Japan: quantifying the benefits and risks of HPV vaccination in quality-adjusted life-years for appropriate decision-making","author":"Kitano T","year":"2019","unstructured":"Kitano T. Stopping the HPV vaccine crisis in Japan: quantifying the benefits and risks of HPV vaccination in quality-adjusted life-years for appropriate decision-making. J Infect Chemother. 2019 Oct 10;26(3):225\u2013230.","journal-title":"J Infect Chemother"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2020.1765619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T11:47:07Z","timestamp":1709293627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2020.1765619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,2]]}},"alternative-id":["10.1080\/21645515.2020.1765619"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2020.1765619","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-02-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}